See where your blood sugar actually sits
Glucose, hemoglobin A1c, insulin, and lipids, read together from one blood draw.
- CLIA-certified labs
- HIPAA compliant
- Personalized health protocol
The symptoms of type 2 diabetes
Type 2 diabetes is a condition in which blood sugar, also called blood glucose, stays too high. The symptoms people notice most often are increased thirst, urinating more often, increased hunger, fatigue, and blurry vision.
Those changes rarely arrive together. Type 2 diabetes symptoms often take several years to develop, and some people notice none at all. Blood sugar can sit high for years without being recognized, because type 2 diabetes develops gradually and may arrive without the classic signs.
Early warning signs you might notice day to day
The first signs turn up in ordinary daily life, long before anyone runs a test.
- Increased thirst: a dryness that drinking does not settle.
- Urinating more often: extra trips through the day, and 1.49 times the risk of getting up at night.
- Increased hunger: hunger that returns soon after a meal.
- Fatigue: tiredness that rest does not fix.
- Blurry vision: frequently a refractive change tracking blood glucose rather than damage to the retina, and sometimes the first thing someone notices.
Later signs of long-standing high blood sugar
Other signs take longer to show up, and several are more common in type 2 diabetes than in type 1.
| Sign | What it suggests is happening |
|---|---|
| Cuts and sores that heal very slowly | High blood sugar and inflammation acting through immune, vascular, and nerve damage |
| Frequent infections | Infection-related hospitalization runs higher in type 2 diabetes, at an incidence rate ratio of 1.88 |
| Numbness or tingling in the hands or feet | Peripheral nerve damage, at a pooled prevalence of 31.5% among people living with type 2 diabetes |
| Losing weight without trying | One of the symptoms shared by both diabetes types |
| Dark patches of skin on the neck, armpits, or groin | A non-invasive surrogate marker of insulin resistance |
Why high blood sugar causes these symptoms
Insulin is a hormone made by the pancreas. Insulin resistance is a condition in which the body does not respond to insulin the way it should, which pushes blood glucose levels up.
Glucose climbs slowly rather than suddenly, which is why symptoms take years to surface and may be absent at earlier stages. Sustained high blood sugar also drives the slower processes behind the later signs. Impaired wound healing traces back to high blood sugar and its associated inflammation.
Type 2 diabetes can be silent for years
Type 2 diabetes can be present with no symptoms at all, and that is common. Worldwide, 42.8% of people with diabetes were undiagnosed in 2024.
The United States looks better, and which definition is used changes the figure. Undiagnosed cases were 17.8% of all diabetes cases from 2017 to March 2020, and 9.5% under a stricter confirmed definition.
Screening for prediabetes and type 2 diabetes is recommended in adults aged 35 to 70 with overweight or obesity and no symptoms.
How type 2 diabetes symptoms differ from type 1
Both conditions share most of the same symptom list. What separates them is the timeline.
| Symptom pattern | Type 2 diabetes | Type 1 diabetes |
|---|---|---|
| How fast symptoms appear | Often several years to develop | Suddenly, in a few weeks or months |
| Severity at first presentation | Some people notice no symptoms | Can be severe |
| How long it goes unrecognized | Frequently undiagnosed for many years | Weeks to months from the first symptom |
| Peripheral neuropathy among people diagnosed | 31.5% pooled prevalence | 17.5% pooled prevalence |
Risk factors for type 2 diabetes
Type 2 diabetes and prediabetes share nearly all their risk factors, because insulin resistance drives both.
- Overweight or obesity
- Age 45 or older
- A parent or sibling with type 2 diabetes
- Physical activity fewer than three times a week
- Non-alcoholic fatty liver disease
- Gestational diabetes, or having given birth to a baby over 9 pounds
- Being African American, Hispanic or Latino, American Indian, or Alaska Native, with higher risk also in some Pacific Islander and Asian American populations
- Polyendocrine metabolic ovarian syndrome (formerly polycystic ovary syndrome) or sleep apnea
Type 2 diabetes in your 20s and 30s
Type 2 diabetes develops in people in their twenties and thirties. Young-onset type 2 diabetes means onset before age 40, and it is increasing worldwide.
Age at onset changes what the condition does. Young-onset type 2 diabetes brings more rapid deterioration of beta-cell function than later-onset disease, and a higher risk of complications than type 1 diabetes. How large that excess risk is remains incompletely understood. A risk factor list weighted toward age 45 or older describes where risk concentrates, not where it begins.
Get 100+ biomarkers tested in-lab or at home
One blood draw a year. A full picture of your health, explained in plain language.
Get 100+ biomarkers tested in-lab or at home
One blood draw a year. A full picture of your health, explained in plain language.
How type 2 diabetes is diagnosed
Type 2 diabetes is confirmed by a blood test run in a laboratory, not by a symptom pattern.
- A1C, the average of the past 2 to 3 months: diabetes at 6.5% or above, and below that prediabetes 5.7% to 6.4%, normal under 5.7%.
- Fasting blood sugar, after at least 8 hours without calories: diabetes at 126 mg/dL or above, and prediabetes at 100 to 125 mg/dL.
- Glucose tolerance test, 2 hours into a 75 g glucose load: diabetes at 200 mg/dL or above.
- Random blood sugar: diabetes at 200 mg/dL or above at any time, alongside classic symptoms.
"Normal" here marks a result below the prediabetes band, not a number to aim at. Screening starts at age 35 in adults with overweight or obesity.
When to see a doctor about these symptoms
Symptoms that persist are a reason to see a clinician and have blood sugar measured. A symptom pattern cannot settle the question, because diagnosis rests on laboratory criteria.
One situation calls for urgent care instead. The hyperosmolar hyperglycemic state is the most serious acute hyperglycemic emergency in type 2 diabetes. It is defined by plasma glucose above 600 mg/dL with high effective plasma osmolality, in the absence of ketoacidosis. Reported mortality runs 10% to 20%, roughly ten times that of diabetic ketoacidosis. Everything short of that emergency shows up in a blood test earlier than in a symptom.
Know your metabolic markers with Superpower
Type 2 diabetes symptoms arrive late, which is the hard part of this condition. A wider read of your biology tells you what a symptom list cannot. A Superpower membership includes 100+ biomarkers in a single draw. Glucose, hemoglobin A1c, insulin, and lipids are measured together, so your metabolic picture arrives at once, not one number at a time. Superpower keeps those results in one place, tracked across draws, with a personalized action plan built around them.
Blood sugar is a number long before it is a symptom. Start your Superpower membership and get your baseline in one draw.
Frequently Asked Questions
References
- Centers for Disease Control and Prevention (2024). *Symptoms of diabetes*. U.S. Department of Health and Human Services. https://www.cdc.gov/diabetes/signs-symptoms/index.html
- American Diabetes Association Professional Practice Committee (2026). 2. Diagnosis and classification of diabetes: Standards of Care in Diabetes—2026. *Diabetes Care*, *49*(Supplement 1), S27–S49. https://doi.org/10.2337/dc26-S002
- Fu Z, Wang F, Dang X, Zhou T (2022). The association between diabetes and nocturia: a systematic review and meta-analysis. *Frontiers in Public Health*, *10*, 924488. https://doi.org/10.3389/fpubh.2022.924488
- Kaštelan S, Gverović-Antunica A, Pelčić G, Gotovac M, Marković I, Kasun B (2018). Refractive changes associated with diabetes mellitus. *Seminars in Ophthalmology*, *33*(7–8), 838–845. https://doi.org/10.1080/08820538.2018.1519582
- Swoboda L, Held J (2022). Impaired wound healing in diabetes. *Journal of Wound Care*, *31*(10), 882–885. https://doi.org/10.12968/jowc.2022.31.10.882
- Carey IM, Critchley JA, DeWilde S, Harris T, Hosking FJ, Cook DG (2018). Risk of infection in type 1 and type 2 diabetes compared with the general population: a matched cohort study. *Diabetes Care*, *41*(3), 513–521. https://doi.org/10.2337/dc17-2131
- Sun J, Wang Y, Zhang X, Zhu S, He H (2020). Prevalence of peripheral neuropathy in patients with diabetes: a systematic review and meta-analysis. *Primary Care Diabetes*, *14*(5), 435–444. https://doi.org/10.1016/j.pcd.2019.12.005
- Radu AM, Carsote M, Dumitrascu MC, Sandru F (2022). Acanthosis nigricans: pointer of endocrine entities. *Diagnostics*, *12*(10), 2519. https://doi.org/10.3390/diagnostics12102519
- National Institute of Diabetes and Digestive and Kidney Diseases (2025). *Insulin resistance & prediabetes*. National Institutes of Health. https://www.niddk.nih.gov/health-information/diabetes/overview/what-is-diabetes/prediabetes-insulin-resistance
- Teufel F, Orgutsova K, Genitsaridi I, Carrillo-Larco RM, Varghese JS, Marcus ME, et al (2026). Global, regional, and national estimates of undiagnosed diabetes in adults: findings from the 2025 IDF Diabetes Atlas. *Diabetes Care*, *49*(3), 490–496. https://doi.org/10.2337/dc25-2583
- Fang M, Wang D, Coresh J, Selvin E (2022). Undiagnosed diabetes in U.S. adults: prevalence and trends. *Diabetes Care*, *45*(9), 1994–2002. https://doi.org/10.2337/dc22-0242
- US Preventive Services Task Force, Davidson KW, Barry MJ, Mangione CM, Cabana M, Caughey AB, et al (2021). Screening for prediabetes and type 2 diabetes: US Preventive Services Task Force recommendation statement. *JAMA*, *326*(8), 736–743. https://doi.org/10.1001/jama.2021.12531
- Centers for Disease Control and Prevention (2024). *Diabetes risk factors*. U.S. Department of Health and Human Services. https://www.cdc.gov/diabetes/risk-factors/index.html
- Magliano DJ, Sacre JW, Harding JL, Gregg EW, Zimmet PZ, Shaw JE (2020). Young-onset type 2 diabetes mellitus — implications for morbidity and mortality. *Nature Reviews Endocrinology*, *16*(6), 321–331. https://doi.org/10.1038/s41574-020-0334-z
- Centers for Disease Control and Prevention (2024). *Diabetes testing*. U.S. Department of Health and Human Services. https://www.cdc.gov/diabetes/diabetes-testing/index.html
- Pasquel FJ, Umpierrez GE (2014). Hyperosmolar hyperglycemic state: a historic review of the clinical presentation, diagnosis, and treatment. *Diabetes Care*, *37*(11), 3124–3131. https://doi.org/10.2337/dc14-0984

















